Akos Czibere
Chief Medical Officer · Aktis Oncology, Inc.
IndividualSelling only4 10b5-1 trades
- 2026
- Sep 24, 2026
- 2
Filings (90d)
Other insiders active in the same stocks
Insiders who reported open-market trades in the last 12 months at the companies Akos Czibere files at. Multiple unrelated insiders buying the same stock within a short window, cluster buying, has historically been one of the strongest Form 4 signals.
- EcoR1 Capital, LLC - $40.00M in AKTS purchases and sales in the last 12 months
- Ansbert Gadicke - $20.03M in AKTS purchases and sales in the last 12 months
- MPM BIOVENTURES 2018, L.P. - $20.03M in AKTS purchases and sales in the last 12 months
- Vida Ventures II, LLC - $15.03M in AKTS purchases and sales in the last 12 months
- Helen Susan Kim - $15.03M in AKTS purchases and sales in the last 12 months
- Todd Foley - $4.19M in AKTS purchases and sales in the last 12 months
More insiders (A-Z)
Browse nearby insider profiles in alphabetical order.
Frequently asked questions
Who is Akos Czibere?
Akos Czibere is a corporate insider, tracked as Chief Medical Officer of Aktis Oncology, Inc. (AKTS). InsiderAlpha holds 2 primary Form 4 filings for them, the earliest from 2026, updated as new SEC EDGAR filings are processed.
How many SEC Form 4 filings has Akos Czibere submitted recently?
1 primary Form 4 filing in the last 90 days, covering 1 company.
Has Akos Czibere been buying or selling stock?
Recorded transactions: 0 open-market purchases and 5 open-market sales ($1.65M) across all tracked filings.
